Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 1/2015

01.08.2015

Etiologies of Sarcoidosis

verfasst von: Edward S. Chen, David R. Moller

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Since sarcoidosis was first described more than a century ago, the etiologic determinants causing this disease remain uncertain. Studies suggest that genetic, host immunologic, and environmental factors interact together to cause sarcoidosis. Immunologic characteristics of sarcoidosis include non-caseating granulomas, enhanced local expression of T helper-1 (and often Th17) cytokines and chemokines, dysfunctional regulatory T-cell responses, dysregulated Toll-like receptor signaling, and oligoclonal expansion of CD4+ T cells consistent with chronic antigenic stimulation. Multiple environmental agents have been suggested to cause sarcoidosis. Studies from several groups implicate mycobacterial or propionibacterial organisms in the etiology of sarcoidosis based on tissue analyses and immunologic responses in sarcoidosis patients. Despite these studies, there is no consensus on the nature of a microbial pathogenesis of sarcoidosis. Some groups postulate sarcoidosis is caused by an active viable replicating infection while other groups contend there is no clinical, pathologic, or microbiologic evidence for such a pathogenic mechanism. The authors posit a novel hypothesis that proposes that sarcoidosis is triggered by a hyperimmune Th1 response to pathogenic microbial and tissue antigens associated with the aberrant aggregation of serum amyloid A within granulomas, which promotes progressive chronic granulomatous inflammation in the absence of ongoing infection.
Literatur
1.
Zurück zum Zitat (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160(2): 736–755 (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160(2): 736–755
2.
Zurück zum Zitat Clay H, Davis JM, Beery D, Huttenlocher A, Lyons SE, Ramakrishnan L (2007) Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. Cell Host Microbe 2(1):29–39PubMedCentralPubMed Clay H, Davis JM, Beery D, Huttenlocher A, Lyons SE, Ramakrishnan L (2007) Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. Cell Host Microbe 2(1):29–39PubMedCentralPubMed
3.
Zurück zum Zitat Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P et al (1996) Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 156(12):4952–4960PubMed Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P et al (1996) Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 156(12):4952–4960PubMed
4.
Zurück zum Zitat Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, O'Neill SJ et al (2000) Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J Immunol 165(8):4718–4724PubMed Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, O'Neill SJ et al (2000) Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J Immunol 165(8):4718–4724PubMed
5.
Zurück zum Zitat Shigehara K, Shijubo N, Ohmichi M, Takahashi R, Kon S, Okamura H et al (2001) IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 166(1):642–649PubMed Shigehara K, Shijubo N, Ohmichi M, Takahashi R, Kon S, Okamura H et al (2001) IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 166(1):642–649PubMed
6.
Zurück zum Zitat Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S et al (2011) Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 66(2):144–150PubMed Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S et al (2011) Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 66(2):144–150PubMed
7.
Zurück zum Zitat Ten Berge B, Paats MS, Bergen IM, van den Blink B, Hoogsteden HC, Lambrecht BN et al (2012) Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology (Oxford) 51(1):37–46 Ten Berge B, Paats MS, Bergen IM, van den Blink B, Hoogsteden HC, Lambrecht BN et al (2012) Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology (Oxford) 51(1):37–46
8.
Zurück zum Zitat Richmond BW, Ploetze K, Isom J, Chambers-Harris I, Braun NA, Taylor T et al (2013) Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-gamma expression. J Clin Immunol 33(2):446–455PubMed Richmond BW, Ploetze K, Isom J, Chambers-Harris I, Braun NA, Taylor T et al (2013) Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-gamma expression. J Clin Immunol 33(2):446–455PubMed
9.
Zurück zum Zitat Romagnani S (2006) Regulation of the T cell response. Clin Exp Allergy 36(11):1357–1366PubMed Romagnani S (2006) Regulation of the T cell response. Clin Exp Allergy 36(11):1357–1366PubMed
10.
Zurück zum Zitat Simonian PL, Roark CL, Wehrmann F, Lanham AK, Diaz de Valle F, Born WK et al (2009) Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J Immunol 182(1):657–665PubMedCentralPubMed Simonian PL, Roark CL, Wehrmann F, Lanham AK, Diaz de Valle F, Born WK et al (2009) Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J Immunol 182(1):657–665PubMedCentralPubMed
11.
Zurück zum Zitat Joshi AD, Fong DJ, Oak SR, Trujillo G, Flaherty KR, Martinez FJ et al (2009) Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. Am J Respir Crit Care Med 179(8):705–716PubMed Joshi AD, Fong DJ, Oak SR, Trujillo G, Flaherty KR, Martinez FJ et al (2009) Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. Am J Respir Crit Care Med 179(8):705–716PubMed
12.
Zurück zum Zitat Su R, Li MM, Bhakta NR, Solberg OD, Darnell EP, Ramstein J et al (2014) Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. Eur Respir J Su R, Li MM, Bhakta NR, Solberg OD, Darnell EP, Ramstein J et al (2014) Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. Eur Respir J
13.
Zurück zum Zitat Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S et al (2006) The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203(2):359–370PubMedCentralPubMed Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S et al (2006) The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203(2):359–370PubMedCentralPubMed
14.
Zurück zum Zitat Taflin C, Miyara M, Nochy D, Valeyre D, Naccache JM, Altare F et al (2009) FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 174(2):497–508PubMedCentralPubMed Taflin C, Miyara M, Nochy D, Valeyre D, Naccache JM, Altare F et al (2009) FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 174(2):497–508PubMedCentralPubMed
15.
Zurück zum Zitat Rappl G, Pabst S, Riemann D, Schmidt A, Wickenhauser C, Schutte W et al (2011) Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation. Clin Immunol 140(1):71–83PubMed Rappl G, Pabst S, Riemann D, Schmidt A, Wickenhauser C, Schutte W et al (2011) Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation. Clin Immunol 140(1):71–83PubMed
16.
Zurück zum Zitat Prasse A, Zissel G, Lutzen N, Schupp J, Schmiedlin R, Gonzalez-Rey E et al (2010) Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. Am J Respir Crit Care Med 182(4):540–548PubMed Prasse A, Zissel G, Lutzen N, Schupp J, Schmiedlin R, Gonzalez-Rey E et al (2010) Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. Am J Respir Crit Care Med 182(4):540–548PubMed
17.
Zurück zum Zitat Lee NS, Barber L, Kanchwala A, Childs CJ, Kataria YP, Judson MA et al (2011) Low levels of NF-kappaB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis. Clin Vaccine Immunol 18(2):223–234PubMedCentralPubMed Lee NS, Barber L, Kanchwala A, Childs CJ, Kataria YP, Judson MA et al (2011) Low levels of NF-kappaB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis. Clin Vaccine Immunol 18(2):223–234PubMedCentralPubMed
18.
Zurück zum Zitat Braun NA, Celada LJ, Herazo-Maya JD, Abraham S, Shaginurova G, Sevin CM et al (2014) Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med 190(5):560–571PubMed Braun NA, Celada LJ, Herazo-Maya JD, Abraham S, Shaginurova G, Sevin CM et al (2014) Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med 190(5):560–571PubMed
19.
Zurück zum Zitat Sverrild A, Backer V, Kyvik KO, Kaprio J, Milman N, Svendsen CB et al (2008) Heredity in sarcoidosis: a registry-based twin study. Thorax 63(10):894–896PubMed Sverrild A, Backer V, Kyvik KO, Kaprio J, Milman N, Svendsen CB et al (2008) Heredity in sarcoidosis: a registry-based twin study. Thorax 63(10):894–896PubMed
20.
Zurück zum Zitat Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA et al (2001) Familial aggregation of sarcoidosis. A case–control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164(11):2085–2091PubMed Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA et al (2001) Familial aggregation of sarcoidosis. A case–control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164(11):2085–2091PubMed
21.
Zurück zum Zitat Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM et al (2010) Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 19(20):4100–4111PubMedCentralPubMed Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM et al (2010) Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 19(20):4100–4111PubMedCentralPubMed
22.
Zurück zum Zitat Darlington P, Gabrielsen A, Sorensson P, Tallstedt L, Padyukov L, Eklund A et al (2014) HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis. Tissue Antigens 83(4):267–272PubMed Darlington P, Gabrielsen A, Sorensson P, Tallstedt L, Padyukov L, Eklund A et al (2014) HLA-alleles associated with increased risk for extra-pulmonary involvement in sarcoidosis. Tissue Antigens 83(4):267–272PubMed
23.
Zurück zum Zitat Ozyilmaz E, Goruroglu Ozturk O, Yunsel D, Deniz A, Hanta I, Kuleci S et al (2014) Could HLA-DR B1*11 allele be a clue for predicting extra-pulmonary sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis 31(2):154–162PubMed Ozyilmaz E, Goruroglu Ozturk O, Yunsel D, Deniz A, Hanta I, Kuleci S et al (2014) Could HLA-DR B1*11 allele be a clue for predicting extra-pulmonary sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis 31(2):154–162PubMed
24.
Zurück zum Zitat Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A (2001) HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 57(1):87–90PubMed Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A (2001) HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 57(1):87–90PubMed
25.
Zurück zum Zitat Grubic Z, Peros-Golubicic T, Stingl K, Zunec R (2011) The investigation of HLA microsatellites influence in predisposition to sarcoidosis among Croatians. Sarcoidosis Vasc Diffuse Lung Dis 28(1):18–26PubMed Grubic Z, Peros-Golubicic T, Stingl K, Zunec R (2011) The investigation of HLA microsatellites influence in predisposition to sarcoidosis among Croatians. Sarcoidosis Vasc Diffuse Lung Dis 28(1):18–26PubMed
26.
Zurück zum Zitat Ishihara M, Ohno S, Ishida T, Ando H, Naruse T, Nose Y et al (1994) Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 43(4):238–241PubMed Ishihara M, Ohno S, Ishida T, Ando H, Naruse T, Nose Y et al (1994) Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 43(4):238–241PubMed
27.
Zurück zum Zitat Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK (2003) Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 29(2):225–231PubMed Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK (2003) Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 29(2):225–231PubMed
28.
Zurück zum Zitat Zhou Y, Shen L, Zhang Y, Jiang D, Li H (2011) Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects. Hum Immunol 72(7):571–575PubMed Zhou Y, Shen L, Zhang Y, Jiang D, Li H (2011) Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects. Hum Immunol 72(7):571–575PubMed
29.
Zurück zum Zitat Grosser M, Luther T, Fuessel M, Bickhardt J, Magdolen V, Baretton G (2005) Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis 22(1):66–74PubMed Grosser M, Luther T, Fuessel M, Bickhardt J, Magdolen V, Baretton G (2005) Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis 22(1):66–74PubMed
30.
Zurück zum Zitat Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A (2006) Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc Diffuse Lung Dis 23(3):180–189PubMed Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A (2006) Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc Diffuse Lung Dis 23(3):180–189PubMed
31.
Zurück zum Zitat Rossman MD, Thompson B, Frederick M, Iannuzzi MC, Rybicki BA, Pander JP et al (2008) HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25(2):125–132PubMed Rossman MD, Thompson B, Frederick M, Iannuzzi MC, Rybicki BA, Pander JP et al (2008) HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25(2):125–132PubMed
32.
Zurück zum Zitat Grunewald J, Hultman T, Bucht A, Eklund A, Wigzell H (1995) Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol Med 1(3):287–296PubMedCentralPubMed Grunewald J, Hultman T, Bucht A, Eklund A, Wigzell H (1995) Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol Med 1(3):287–296PubMedCentralPubMed
33.
Zurück zum Zitat Darlington P, Haugom-Olsen H, von Sivers K, Wahlstrom J, Runold M, Svjatoha V et al (2012) T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis—indication for an airborne antigen as the triggering factor in sarcoidosis. J Intern Med 272(5):465–471PubMed Darlington P, Haugom-Olsen H, von Sivers K, Wahlstrom J, Runold M, Svjatoha V et al (2012) T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis—indication for an airborne antigen as the triggering factor in sarcoidosis. J Intern Med 272(5):465–471PubMed
34.
Zurück zum Zitat Kuroda H, Saijo Y, Fujiuchi S, Takeda H, Ohsaki Y, Hasebe N (2013) Relationship between cytokine single nucleotide polymorphisms and sarcoidosis among Japanese subjects. Sarcoidosis Vasc Diffuse Lung Dis 30(1):36–42PubMed Kuroda H, Saijo Y, Fujiuchi S, Takeda H, Ohsaki Y, Hasebe N (2013) Relationship between cytokine single nucleotide polymorphisms and sarcoidosis among Japanese subjects. Sarcoidosis Vasc Diffuse Lung Dis 30(1):36–42PubMed
35.
Zurück zum Zitat Seitzer U, Swider C, Stuber F, Suchnicki K, Lange A, Richter E et al (1997) Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 9(10):787–790PubMed Seitzer U, Swider C, Stuber F, Suchnicki K, Lange A, Richter E et al (1997) Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 9(10):787–790PubMed
36.
Zurück zum Zitat Fischer A, Nothnagel M, Schurmann M, Muller-Quernheim J, Schreiber S, Hofmann S (2010) A genome-wide linkage analysis in 181 German sarcoidosis families using clustered biallelic markers. Chest 138(1):151–157PubMed Fischer A, Nothnagel M, Schurmann M, Muller-Quernheim J, Schreiber S, Hofmann S (2010) A genome-wide linkage analysis in 181 German sarcoidosis families using clustered biallelic markers. Chest 138(1):151–157PubMed
37.
Zurück zum Zitat Chen ES, Song Z, Willett MH, Heine S, Yung RC, Liu MC et al (2010) Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med 181(4):360–373PubMedCentralPubMed Chen ES, Song Z, Willett MH, Heine S, Yung RC, Liu MC et al (2010) Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med 181(4):360–373PubMedCentralPubMed
38.
Zurück zum Zitat Wiken M, Grunewald J, Eklund A, Wahlstrom J (2009) Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol 29(1):78–89PubMed Wiken M, Grunewald J, Eklund A, Wahlstrom J (2009) Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol 29(1):78–89PubMed
39.
Zurück zum Zitat Gabrilovich MI, Walrath J, van Lunteren J, Nethery D, Seifu M, Kern JA et al (2013) Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol 173(3):512–522PubMedCentralPubMed Gabrilovich MI, Walrath J, van Lunteren J, Nethery D, Seifu M, Kern JA et al (2013) Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol 173(3):512–522PubMedCentralPubMed
40.
Zurück zum Zitat Veltkamp M, van Moorsel CH, Rijkers GT, Ruven HJ, Grutters JC (2012) Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue Antigens 79(1):25–32PubMed Veltkamp M, van Moorsel CH, Rijkers GT, Ruven HJ, Grutters JC (2012) Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue Antigens 79(1):25–32PubMed
41.
Zurück zum Zitat Veltkamp M, Wijnen PA, van Moorsel CH, Rijkers GT, Ruven HJ, Heron M et al (2007) Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 149(3):453–462PubMedCentralPubMed Veltkamp M, Wijnen PA, van Moorsel CH, Rijkers GT, Ruven HJ, Heron M et al (2007) Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 149(3):453–462PubMedCentralPubMed
42.
Zurück zum Zitat Sato M, Kawagoe T, Meguro A, Ota M, Katsuyama Y, Ishihara M et al (2011) Toll-like receptor 2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population. Mol Vis 17:731–736PubMedCentralPubMed Sato M, Kawagoe T, Meguro A, Ota M, Katsuyama Y, Ishihara M et al (2011) Toll-like receptor 2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population. Mol Vis 17:731–736PubMedCentralPubMed
43.
Zurück zum Zitat Rastogi R, Du W, Ju D, Pirockinaite G, Liu Y, Nunez G et al (2011) Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells. Am J Respir Crit Care Med 183(4):500–510PubMed Rastogi R, Du W, Ju D, Pirockinaite G, Liu Y, Nunez G et al (2011) Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells. Am J Respir Crit Care Med 183(4):500–510PubMed
44.
Zurück zum Zitat Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S et al (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105(3):1195–1197PubMed Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S et al (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105(3):1195–1197PubMed
45.
Zurück zum Zitat Martin TM, Doyle TM, Smith JR, Dinulescu D, Rust K, Rosenbaum JT (2003) Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 136(5):933–935PubMed Martin TM, Doyle TM, Smith JR, Dinulescu D, Rust K, Rosenbaum JT (2003) Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am J Ophthalmol 136(5):933–935PubMed
46.
Zurück zum Zitat Schurmann M, Valentonyte R, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S (2003) CARD15 gene mutations in sarcoidosis. Eur Respir J: Off J Eur Soc Clin Respir Physiol 22(5):748–754 Schurmann M, Valentonyte R, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S (2003) CARD15 gene mutations in sarcoidosis. Eur Respir J: Off J Eur Soc Clin Respir Physiol 22(5):748–754
47.
Zurück zum Zitat Milman N, Nielsen OH, Hviid TV, Fenger K (2007) CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis. Respiration 74(1):76–79PubMed Milman N, Nielsen OH, Hviid TV, Fenger K (2007) CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis. Respiration 74(1):76–79PubMed
48.
Zurück zum Zitat Akahoshi M, Ishihara M, Namba K, Kitaichi N, Ando Y, Takenaka S et al (2008) Mutation screening of the CARD15 gene in sarcoidosis. Tissue Antigens 71(6):564–567PubMed Akahoshi M, Ishihara M, Namba K, Kitaichi N, Ando Y, Takenaka S et al (2008) Mutation screening of the CARD15 gene in sarcoidosis. Tissue Antigens 71(6):564–567PubMed
49.
Zurück zum Zitat Campo I, Morbini P, Zorzetto M, Tinelli C, Brunetta E, Villa C et al (2007) Expression of receptor for advanced glycation end products in sarcoid granulomas. Am J Respir Crit Care Med 175(5):498–506PubMed Campo I, Morbini P, Zorzetto M, Tinelli C, Brunetta E, Villa C et al (2007) Expression of receptor for advanced glycation end products in sarcoid granulomas. Am J Respir Crit Care Med 175(5):498–506PubMed
50.
Zurück zum Zitat Kim MH, Choi YW, Choi HY, Myung KB, Cho SN (2006) The expression of RAGE and EN-RAGE in leprosy. Br J Dermatol 154(4):594–601PubMed Kim MH, Choi YW, Choi HY, Myung KB, Cho SN (2006) The expression of RAGE and EN-RAGE in leprosy. Br J Dermatol 154(4):594–601PubMed
51.
Zurück zum Zitat Sakaguchi M, Murata H, Yamamoto K, Ono T, Sakaguchi Y, Motoyama A et al (2011) TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One 6(8):e23132PubMedCentralPubMed Sakaguchi M, Murata H, Yamamoto K, Ono T, Sakaguchi Y, Motoyama A et al (2011) TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One 6(8):e23132PubMedCentralPubMed
52.
Zurück zum Zitat Akira S (2003) Mammalian Toll-like receptors. Curr Opin Immunol 15(1):5–11PubMed Akira S (2003) Mammalian Toll-like receptors. Curr Opin Immunol 15(1):5–11PubMed
53.
Zurück zum Zitat Daniil Z, Mollaki V, Malli F, Koutsokera A, Antoniou KM, Rodopoulou P et al (2013) Polymorphisms and haplotypes in MyD88 are associated with the development of sarcoidosis: a candidate-gene association study. Mol Biol Rep 40(7):4281–4286PubMed Daniil Z, Mollaki V, Malli F, Koutsokera A, Antoniou KM, Rodopoulou P et al (2013) Polymorphisms and haplotypes in MyD88 are associated with the development of sarcoidosis: a candidate-gene association study. Mol Biol Rep 40(7):4281–4286PubMed
54.
Zurück zum Zitat Belkaid Y (2007) Regulatory T, cells and infection: a dangerous necessity. Nat Rev Immunol 7(11):875–888PubMed Belkaid Y (2007) Regulatory T, cells and infection: a dangerous necessity. Nat Rev Immunol 7(11):875–888PubMed
55.
Zurück zum Zitat Trinath J, Maddur MS, Kaveri SV, Balaji KN, Bayry J (2012) Mycobacterium tuberculosis promotes regulatory T-cell expansion via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells. J Infect Dis 205(4):694–696PubMed Trinath J, Maddur MS, Kaveri SV, Balaji KN, Bayry J (2012) Mycobacterium tuberculosis promotes regulatory T-cell expansion via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells. J Infect Dis 205(4):694–696PubMed
56.
Zurück zum Zitat Wilsher ML (1998) Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J 12(5):1197–1199PubMed Wilsher ML (1998) Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J 12(5):1197–1199PubMed
57.
Zurück zum Zitat Izbicki G, Chavko R, Banauch GI, Weiden MD, Berger KI, Aldrich TK et al (2007) World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131(5):1414–1423PubMed Izbicki G, Chavko R, Banauch GI, Weiden MD, Berger KI, Aldrich TK et al (2007) World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131(5):1414–1423PubMed
58.
Zurück zum Zitat Kreider ME, Christie JD, Thompson B, Newman L, Rose C, Barnard J et al (2005) Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 128(1):207–215PubMed Kreider ME, Christie JD, Thompson B, Newman L, Rose C, Barnard J et al (2005) Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 128(1):207–215PubMed
59.
Zurück zum Zitat Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M et al (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170(12):1324–1330PubMed Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M et al (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170(12):1324–1330PubMed
60.
Zurück zum Zitat Barnard J, Rose C, Newman L, Canner M, Martyny J, McCammon C et al (2005) Job and industry classifications associated with sarcoidosis in A Case–Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 47(3):226–234PubMed Barnard J, Rose C, Newman L, Canner M, Martyny J, McCammon C et al (2005) Job and industry classifications associated with sarcoidosis in A Case–Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 47(3):226–234PubMed
61.
Zurück zum Zitat Newman LS (1996) Immunology, genetics, and epidemiology of beryllium disease. Chest 109(3 Suppl):40S–43SPubMed Newman LS (1996) Immunology, genetics, and epidemiology of beryllium disease. Chest 109(3 Suppl):40S–43SPubMed
62.
Zurück zum Zitat Muller-Quernheim J, Gaede KI, Fireman E, Zissel G (2006) Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 27(6):1190–1195PubMed Muller-Quernheim J, Gaede KI, Fireman E, Zissel G (2006) Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 27(6):1190–1195PubMed
63.
Zurück zum Zitat Mack DG, Falta MT, McKee AS, Martin AK, Simonian PL, Crawford F et al (2014) Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease. Proc Natl Acad Sci U S A 111(23):8553–8558PubMedCentralPubMed Mack DG, Falta MT, McKee AS, Martin AK, Simonian PL, Crawford F et al (2014) Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease. Proc Natl Acad Sci U S A 111(23):8553–8558PubMedCentralPubMed
64.
Zurück zum Zitat Respiratory illness in workers exposed to metalworking fluid contaminated with nontuberculous mycobacteria—Ohio, 2001. MMWR Morb Mortal Wkly Rep (2002) 51(16): 349–352 Respiratory illness in workers exposed to metalworking fluid contaminated with nontuberculous mycobacteria—Ohio, 2001. MMWR Morb Mortal Wkly Rep (2002) 51(16): 349–352
65.
Zurück zum Zitat Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI et al (2005) Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289(5):L698–L708PubMed Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI et al (2005) Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289(5):L698–L708PubMed
66.
Zurück zum Zitat Huizar I, Malur A, Patel J, McPeek M, Dobbs L, Wingard C et al (2013) The role of PPARgamma in carbon nanotube-elicited granulomatous lung inflammation. Respir Res 14:7PubMedCentralPubMed Huizar I, Malur A, Patel J, McPeek M, Dobbs L, Wingard C et al (2013) The role of PPARgamma in carbon nanotube-elicited granulomatous lung inflammation. Respir Res 14:7PubMedCentralPubMed
67.
Zurück zum Zitat Barna BP, Huizar I, Malur A, McPeek M, Marshall I, Jacob M et al (2013) Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation. Int J Mol Sci 14(12):23858–23871PubMedCentralPubMed Barna BP, Huizar I, Malur A, McPeek M, Marshall I, Jacob M et al (2013) Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation. Int J Mol Sci 14(12):23858–23871PubMedCentralPubMed
68.
Zurück zum Zitat Judson MA, Baughman RP (2014) How many organs need to be involved to diagnose sarcoidosis?: An unanswered question that, hopefully, will become irrelevant. Sarcoidosis Vasc Diffuse Lung Dis 31(1):6–7PubMed Judson MA, Baughman RP (2014) How many organs need to be involved to diagnose sarcoidosis?: An unanswered question that, hopefully, will become irrelevant. Sarcoidosis Vasc Diffuse Lung Dis 31(1):6–7PubMed
69.
Zurück zum Zitat Heyll A, Meckenstock G, Aul C, Sohngen D, Borchard F, Hadding U et al (1994) Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 14(1):161–164PubMed Heyll A, Meckenstock G, Aul C, Sohngen D, Borchard F, Hadding U et al (1994) Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 14(1):161–164PubMed
70.
Zurück zum Zitat Sundar KM, Carveth HJ, Gosselin MV, Beatty PG, Colby TV, Hoidal JR (2001) Granulomatous pneumonitis following bone marrow transplantation. Bone Marrow Transplant 28(6):627–630PubMed Sundar KM, Carveth HJ, Gosselin MV, Beatty PG, Colby TV, Hoidal JR (2001) Granulomatous pneumonitis following bone marrow transplantation. Bone Marrow Transplant 28(6):627–630PubMed
71.
Zurück zum Zitat Gooneratne L, Lim ZY, Vivier A, Salisbury JR, Knisely AS, Ho AY et al (2007) Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation. Bone Marrow Transplant 39(8):511–512PubMed Gooneratne L, Lim ZY, Vivier A, Salisbury JR, Knisely AS, Ho AY et al (2007) Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation. Bone Marrow Transplant 39(8):511–512PubMed
72.
Zurück zum Zitat Morita R, Hashino S, Kubota K, Onozawa M, Kahata K, Kondo T et al (2009) Donor cell-derived sarcoidosis after allogeneic BMT. Bone Marrow Transplant 43(6):507–508PubMed Morita R, Hashino S, Kubota K, Onozawa M, Kahata K, Kondo T et al (2009) Donor cell-derived sarcoidosis after allogeneic BMT. Bone Marrow Transplant 43(6):507–508PubMed
73.
Zurück zum Zitat Johnson BA, Duncan SR, Ohori NP, Paradis IL, Yousem SA, Grgurich WF et al (1993) Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis 148(5):1373–1377PubMed Johnson BA, Duncan SR, Ohori NP, Paradis IL, Yousem SA, Grgurich WF et al (1993) Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis 148(5):1373–1377PubMed
74.
Zurück zum Zitat Ramakers K, De Wever W, Coolen J, Verschakelen J (2012) Recurrent sarcoidosis after lung transplantation. JBR-BTR 95(6):368PubMed Ramakers K, De Wever W, Coolen J, Verschakelen J (2012) Recurrent sarcoidosis after lung transplantation. JBR-BTR 95(6):368PubMed
75.
Zurück zum Zitat Fidler HM, Hadziyannis SJ, Dhillon AP, Sherlock S, Burroughs AK (1997) Recurrent hepatic sarcoidosis following liver transplantation. Transplant Proc 29(5):2509–2510PubMed Fidler HM, Hadziyannis SJ, Dhillon AP, Sherlock S, Burroughs AK (1997) Recurrent hepatic sarcoidosis following liver transplantation. Transplant Proc 29(5):2509–2510PubMed
76.
Zurück zum Zitat Vanatta JM, Modanlou KA, Dean AG, Nezakatgoo N, Campos L, Nair S et al (2011) Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: an analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl 17(9):1027–1034PubMed Vanatta JM, Modanlou KA, Dean AG, Nezakatgoo N, Campos L, Nair S et al (2011) Outcomes of orthotopic liver transplantation for hepatic sarcoidosis: an analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network data files for a comparative study with cholestatic liver diseases. Liver Transpl 17(9):1027–1034PubMed
77.
Zurück zum Zitat Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM et al (1992) Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 11(2 Pt 1):367–369PubMed Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM et al (1992) Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 11(2 Pt 1):367–369PubMed
78.
Zurück zum Zitat Akashi H, Kato TS, Takayama H, Naka Y, Farr M, Mancini D et al (2012) Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation—single-center retrospective analysis. J Cardiol 60(5):407–410PubMed Akashi H, Kato TS, Takayama H, Naka Y, Farr M, Mancini D et al (2012) Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation—single-center retrospective analysis. J Cardiol 60(5):407–410PubMed
79.
Zurück zum Zitat Shen SY, Hall-Craggs M, Posner JN, Shabazz B (1986) Recurrent sarcoid granulomatous nephritis and reactive tuberculin skin test in a renal transplant recipient. Am J Med 80(4):699–702PubMed Shen SY, Hall-Craggs M, Posner JN, Shabazz B (1986) Recurrent sarcoid granulomatous nephritis and reactive tuberculin skin test in a renal transplant recipient. Am J Med 80(4):699–702PubMed
80.
Zurück zum Zitat Aouizerate J, Matignon M, Kamar N, Thervet E, Randoux C, Moulin B et al (2010) Renal transplantation in patients with sarcoidosis: a French multicenter study. Clin J Am Soc Nephrol 5(11):2101–2108PubMedCentralPubMed Aouizerate J, Matignon M, Kamar N, Thervet E, Randoux C, Moulin B et al (2010) Renal transplantation in patients with sarcoidosis: a French multicenter study. Clin J Am Soc Nephrol 5(11):2101–2108PubMedCentralPubMed
81.
Zurück zum Zitat Milman N, Andersen CB, Burton CM, Iversen M (2005) Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells. Eur Respir J 26(3):549–552PubMed Milman N, Andersen CB, Burton CM, Iversen M (2005) Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells. Eur Respir J 26(3):549–552PubMed
82.
Zurück zum Zitat Pukiat S, McCarthy PL Jr, Hahn T, Morrison C, Shanahan T, Qiu J et al (2011) Sarcoidosis-associated MHC Ags and the development of cutaneous and nodal granulomas following allogeneic hematopoietic cell transplant. Bone Marrow Transplant 46(7):1032–1034PubMed Pukiat S, McCarthy PL Jr, Hahn T, Morrison C, Shanahan T, Qiu J et al (2011) Sarcoidosis-associated MHC Ags and the development of cutaneous and nodal granulomas following allogeneic hematopoietic cell transplant. Bone Marrow Transplant 46(7):1032–1034PubMed
83.
84.
Zurück zum Zitat Kooij R, Gerritsen T (1958) On the nature of the Mitsuda and the Kveim reaction. Dermatologica 116(1):1–27PubMed Kooij R, Gerritsen T (1958) On the nature of the Mitsuda and the Kveim reaction. Dermatologica 116(1):1–27PubMed
85.
Zurück zum Zitat Klein JT, Horn TD, Forman JD, Silver RF, Teirstein AS, Moller DR (1995) Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 154(3):1450–1460PubMed Klein JT, Horn TD, Forman JD, Silver RF, Teirstein AS, Moller DR (1995) Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 154(3):1450–1460PubMed
86.
Zurück zum Zitat Segal JL, Thompson JF, Charter RA (2012) A novel immunogen to modulate cytokine production and promote immune system reconstitution in HIV-AIDS. Am J Ther 19(5):317–323PubMed Segal JL, Thompson JF, Charter RA (2012) A novel immunogen to modulate cytokine production and promote immune system reconstitution in HIV-AIDS. Am J Ther 19(5):317–323PubMed
87.
Zurück zum Zitat Milman N, Lisby G, Friis S, Kemp L (2004) Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study. Sarcoidosis Vasc Diffuse Lung Dis 21(1):25–28PubMed Milman N, Lisby G, Friis S, Kemp L (2004) Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study. Sarcoidosis Vasc Diffuse Lung Dis 21(1):25–28PubMed
88.
Zurück zum Zitat Brown ST, Brett I, Almenoff PL, Lesser M, Terrin M, Teirstein AS (2003) Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 123(2):413–417PubMed Brown ST, Brett I, Almenoff PL, Lesser M, Terrin M, Teirstein AS (2003) Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 123(2):413–417PubMed
89.
Zurück zum Zitat Gupta D, Agarwal R, Aggarwal AN, Jindal SK (2007) Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 30(3):508–516PubMed Gupta D, Agarwal R, Aggarwal AN, Jindal SK (2007) Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 30(3):508–516PubMed
90.
Zurück zum Zitat Zhou Y, Li HP, Li QH, Zheng H, Zhang RX, Chen G et al (2008) Differentiation of sarcoidosis from tuberculosis using real-time PCR assay for the detection and quantification of Mycobacterium tuberculosis. Sarcoidosis Vasculitis Diffuse Lung Dis: Off J WASOG / World Assoc Sarcoidosis Other Granulomatous Disord 25(2):93–99 Zhou Y, Li HP, Li QH, Zheng H, Zhang RX, Chen G et al (2008) Differentiation of sarcoidosis from tuberculosis using real-time PCR assay for the detection and quantification of Mycobacterium tuberculosis. Sarcoidosis Vasculitis Diffuse Lung Dis: Off J WASOG / World Assoc Sarcoidosis Other Granulomatous Disord 25(2):93–99
91.
Zurück zum Zitat Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB et al (2005) Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 201(5):755–767PubMedCentralPubMed Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB et al (2005) Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 201(5):755–767PubMedCentralPubMed
92.
Zurück zum Zitat Chen ES, Wahlstrom J, Song Z, Willett MH, Wiken M, Yung RC et al (2008) T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 181(12):8784–8796PubMedCentralPubMed Chen ES, Wahlstrom J, Song Z, Willett MH, Wiken M, Yung RC et al (2008) T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 181(12):8784–8796PubMedCentralPubMed
93.
Zurück zum Zitat Hanngren A, Odham G, Eklund A, Hoffner S, Stjernberg N, Westerdahl G (1987) Tuberculostearic acid in lymph nodes from patients with sarcoidosis. Sarcoidosis 4(2):101–104PubMed Hanngren A, Odham G, Eklund A, Hoffner S, Stjernberg N, Westerdahl G (1987) Tuberculostearic acid in lymph nodes from patients with sarcoidosis. Sarcoidosis 4(2):101–104PubMed
94.
Zurück zum Zitat Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A, Zwolska Z, Izycka-Swieszewska E, Augustynowicz-Kopec E et al (2006) Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol 44(9):3448–3451PubMedCentralPubMed Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A, Zwolska Z, Izycka-Swieszewska E, Augustynowicz-Kopec E et al (2006) Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol 44(9):3448–3451PubMedCentralPubMed
95.
Zurück zum Zitat Oswald-Richter KA, Beachboard DC, Seeley EH, Abraham S, Shepherd BE, Jenkins CA et al (2012) Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol 32(5):1129–1140PubMedCentralPubMed Oswald-Richter KA, Beachboard DC, Seeley EH, Abraham S, Shepherd BE, Jenkins CA et al (2012) Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol 32(5):1129–1140PubMedCentralPubMed
96.
Zurück zum Zitat Chapman JS (1961) Mycobacterial and mycotic antibodies in sera of patients with sarcoidosis. Results of studies using agar double-diffusion technique. Ann Intern Med 55:918–924PubMed Chapman JS (1961) Mycobacterial and mycotic antibodies in sera of patients with sarcoidosis. Results of studies using agar double-diffusion technique. Ann Intern Med 55:918–924PubMed
97.
Zurück zum Zitat Reid JD, Chiodini RJ (1993) Serologic reactivity against Mycobacterium paratuberculosis antigens in patients with sarcoidosis. Sarcoidosis 10(1):32–35PubMed Reid JD, Chiodini RJ (1993) Serologic reactivity against Mycobacterium paratuberculosis antigens in patients with sarcoidosis. Sarcoidosis 10(1):32–35PubMed
98.
Zurück zum Zitat Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R et al (2007) Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 75(1):527–530PubMedCentralPubMed Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R et al (2007) Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 75(1):527–530PubMedCentralPubMed
99.
Zurück zum Zitat Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Singh M, Mysliwski A (2007) Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 12(3):346–354PubMed Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Singh M, Mysliwski A (2007) Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 12(3):346–354PubMed
100.
Zurück zum Zitat Oswald-Richter KA, Beachboard DC, Zhan X, Gaskill CF, Abraham S, Jenkins C et al (2010) Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir Res 11:161PubMedCentralPubMed Oswald-Richter KA, Beachboard DC, Zhan X, Gaskill CF, Abraham S, Jenkins C et al (2010) Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir Res 11:161PubMedCentralPubMed
101.
Zurück zum Zitat Agarwal R, Gupta D, Srinivas R, Verma I, Aggarwal AN, Laal S (2012) Analysis of humoral responses to proteins encoded by region of difference 1 of Mycobacterium tuberculosis in sarcoidosis in a high tuberculosis prevalence country. Indian J Med Res 135(6):920–923PubMedCentralPubMed Agarwal R, Gupta D, Srinivas R, Verma I, Aggarwal AN, Laal S (2012) Analysis of humoral responses to proteins encoded by region of difference 1 of Mycobacterium tuberculosis in sarcoidosis in a high tuberculosis prevalence country. Indian J Med Res 135(6):920–923PubMedCentralPubMed
102.
Zurück zum Zitat Ahmadzai H, Cameron B, Chui JJ, Lloyd A, Wakefield D, Thomas PS (2012) Peripheral blood responses to specific antigens and CD28 in sarcoidosis. Respir Med 106(5):701–709PubMed Ahmadzai H, Cameron B, Chui JJ, Lloyd A, Wakefield D, Thomas PS (2012) Peripheral blood responses to specific antigens and CD28 in sarcoidosis. Respir Med 106(5):701–709PubMed
103.
Zurück zum Zitat Inui N, Suda T, Chida K (2008) Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis. Respir Med 102(2):313–315PubMed Inui N, Suda T, Chida K (2008) Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis. Respir Med 102(2):313–315PubMed
104.
Zurück zum Zitat Horster R, Kirsten D, Gaede KI, Jafari C, Strassburg A, Greinert U et al (2009) Antimycobacterial immune responses in patients with pulmonary sarcoidosis. Clin Respir J 3(4):229–238PubMed Horster R, Kirsten D, Gaede KI, Jafari C, Strassburg A, Greinert U et al (2009) Antimycobacterial immune responses in patients with pulmonary sarcoidosis. Clin Respir J 3(4):229–238PubMed
105.
Zurück zum Zitat Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA et al (2003) HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73(4):720–735PubMedCentralPubMed Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA et al (2003) HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73(4):720–735PubMedCentralPubMed
106.
Zurück zum Zitat Saltini C, Pallante M, Puxeddu E, Contini S, Voorter CE, Drent M et al (2008) M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasculitis Diffuse Lung Dis: Off J WASOG / World Assoc Sarcoidosis Other Granulomatous Disord 25(2):100–116 Saltini C, Pallante M, Puxeddu E, Contini S, Voorter CE, Drent M et al (2008) M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasculitis Diffuse Lung Dis: Off J WASOG / World Assoc Sarcoidosis Other Granulomatous Disord 25(2):100–116
107.
Zurück zum Zitat Wiken M, Ostadkarampour M, Eklund A, Willett M, Chen E, Moller D et al (2012) Antigen-specific multifunctional T-cells in sarcoidosis patients with Lofgren’s syndrome. Eur Respir J 40(1):110–121PubMed Wiken M, Ostadkarampour M, Eklund A, Willett M, Chen E, Moller D et al (2012) Antigen-specific multifunctional T-cells in sarcoidosis patients with Lofgren’s syndrome. Eur Respir J 40(1):110–121PubMed
108.
Zurück zum Zitat Koth LL, Solberg OD, Peng JC, Bhakta NR, Nguyen CP, Woodruff PG (2011) Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respir Crit Care Med 184(10):1153–1163PubMedCentralPubMed Koth LL, Solberg OD, Peng JC, Bhakta NR, Nguyen CP, Woodruff PG (2011) Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respir Crit Care Med 184(10):1153–1163PubMedCentralPubMed
109.
Zurück zum Zitat Thillai M, Eberhardt C, Lewin AM, Potiphar L, Hingley-Wilson S, Sridhar S et al (2012) Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood. PLoS One 7(7):e38083PubMedCentralPubMed Thillai M, Eberhardt C, Lewin AM, Potiphar L, Hingley-Wilson S, Sridhar S et al (2012) Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood. PLoS One 7(7):e38083PubMedCentralPubMed
110.
Zurück zum Zitat Maertzdorf J, Weiner J 3rd, Mollenkopf HJ, Bauer T, Prasse A, Muller-Quernheim J et al (2012) Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A 109(20):7853–7858PubMedCentralPubMed Maertzdorf J, Weiner J 3rd, Mollenkopf HJ, Bauer T, Prasse A, Muller-Quernheim J et al (2012) Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A 109(20):7853–7858PubMedCentralPubMed
111.
Zurück zum Zitat Zhou T, Zhang W, Sweiss NJ, Chen ES, Moller DR, Knox KS et al (2012) Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PLoS One 7(9):e44818PubMedCentralPubMed Zhou T, Zhang W, Sweiss NJ, Chen ES, Moller DR, Knox KS et al (2012) Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PLoS One 7(9):e44818PubMedCentralPubMed
112.
Zurück zum Zitat Goyal B, Kumar K, Gupta D, Agarwal R, Latawa R, Sheikh JA et al (2014) Utility of B-cell epitopes based peptides of RD1 and RD2 antigens for immunodiagnosis of pulmonary tuberculosis. Diagn Microbiol Infect Dis 78(4):391–397PubMed Goyal B, Kumar K, Gupta D, Agarwal R, Latawa R, Sheikh JA et al (2014) Utility of B-cell epitopes based peptides of RD1 and RD2 antigens for immunodiagnosis of pulmonary tuberculosis. Diagn Microbiol Infect Dis 78(4):391–397PubMed
113.
Zurück zum Zitat Homma JY, Abe C, Chosa H, Ueda K, Saegusa J, Nakayama M et al (1978) Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med 48(3):251–255PubMed Homma JY, Abe C, Chosa H, Ueda K, Saegusa J, Nakayama M et al (1978) Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med 48(3):251–255PubMed
114.
Zurück zum Zitat Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T et al (2002) Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40(1):198–204PubMedCentralPubMed Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T et al (2002) Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40(1):198–204PubMedCentralPubMed
115.
Zurück zum Zitat Ebe Y, Ikushima S, Yamaguchi T, Kohno K, Azuma A, Sato K et al (2000) Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 17(3):256–265PubMed Ebe Y, Ikushima S, Yamaguchi T, Kohno K, Azuma A, Sato K et al (2000) Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 17(3):256–265PubMed
116.
Zurück zum Zitat Nishiwaki T, Yoneyama H, Eishi Y, Matsuo N, Tatsumi K, Kimura H et al (2004) Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 165(2):631–639PubMedCentralPubMed Nishiwaki T, Yoneyama H, Eishi Y, Matsuo N, Tatsumi K, Kimura H et al (2004) Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 165(2):631–639PubMedCentralPubMed
117.
Zurück zum Zitat McCaskill JG, Chason KD, Hua X, Neuringer IP, Ghio AJ, Funkhouser WK et al (2006) Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice. Am J Respir Cell Mol Biol 35(3):347–356PubMedCentralPubMed McCaskill JG, Chason KD, Hua X, Neuringer IP, Ghio AJ, Funkhouser WK et al (2006) Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice. Am J Respir Cell Mol Biol 35(3):347–356PubMedCentralPubMed
118.
Zurück zum Zitat Ishige I, Eishi Y, Takemura T, Kobayashi I, Nakata K, Tanaka I et al (2005) Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22(1):33–42PubMed Ishige I, Eishi Y, Takemura T, Kobayashi I, Nakata K, Tanaka I et al (2005) Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22(1):33–42PubMed
119.
Zurück zum Zitat Eishi Y (2013) Etiologic link between sarcoidosis and Propionibacterium acnes. Respir Investig 51(2):56–68PubMed Eishi Y (2013) Etiologic link between sarcoidosis and Propionibacterium acnes. Respir Investig 51(2):56–68PubMed
120.
Zurück zum Zitat Fretzayas A, Moustaki M, Priftis KN, Yiallouros P, Paschalidou M, Nicolaidou P (2011) Bilateral hilar lymphadenopathy due to Chlamydia pneumoniae infection. Pediatr Pulmonol 46(10):1038–1040PubMed Fretzayas A, Moustaki M, Priftis KN, Yiallouros P, Paschalidou M, Nicolaidou P (2011) Bilateral hilar lymphadenopathy due to Chlamydia pneumoniae infection. Pediatr Pulmonol 46(10):1038–1040PubMed
121.
Zurück zum Zitat Yano S, Kobayashi K, Ikeda T, Kadowaki T, Wakabayashi K, Kimura M et al (2012) Sarcoid-like reaction in Cryptococcus neoformans infection. BMJ Case Rep 2012 Yano S, Kobayashi K, Ikeda T, Kadowaki T, Wakabayashi K, Kimura M et al (2012) Sarcoid-like reaction in Cryptococcus neoformans infection. BMJ Case Rep 2012
122.
Zurück zum Zitat Mathur P, Zurlo JJ, Crook TJ (2014) The intricate relationship of histoplasmosis and sarcoidosis: a case report. J Med Case Rep 8:235PubMedCentralPubMed Mathur P, Zurlo JJ, Crook TJ (2014) The intricate relationship of histoplasmosis and sarcoidosis: a case report. J Med Case Rep 8:235PubMedCentralPubMed
123.
Zurück zum Zitat Yang DJ, Krishnan RS, Guillen DR, Schmiege LM 3rd, Leis PF, Hsu S (2006) Disseminated sporotrichosis mimicking sarcoidosis. Int J Dermatol 45(4):450–453PubMed Yang DJ, Krishnan RS, Guillen DR, Schmiege LM 3rd, Leis PF, Hsu S (2006) Disseminated sporotrichosis mimicking sarcoidosis. Int J Dermatol 45(4):450–453PubMed
124.
Zurück zum Zitat Lebbe C, Agbalika F, Flageul B, Pellet C, Rybojad M, Cordoliani F et al (1999) No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis. Br J Dermatol 141(3):492–496PubMed Lebbe C, Agbalika F, Flageul B, Pellet C, Rybojad M, Cordoliani F et al (1999) No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis. Br J Dermatol 141(3):492–496PubMed
125.
Zurück zum Zitat Biberfeld P, Petren AL, Eklund A, Lindemalm C, Barkhem T, Ekman M et al (1988) Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders. J Virol Methods 21(1–4):49–59PubMed Biberfeld P, Petren AL, Eklund A, Lindemalm C, Barkhem T, Ekman M et al (1988) Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders. J Virol Methods 21(1–4):49–59PubMed
126.
Zurück zum Zitat Di Alberti L, Piattelli A, Artese L, Favia G, Patel S, Saunders N et al (1997) Human herpesvirus 8 variants in sarcoid tissues. Lancet 350(9092):1655–1661PubMed Di Alberti L, Piattelli A, Artese L, Favia G, Patel S, Saunders N et al (1997) Human herpesvirus 8 variants in sarcoid tissues. Lancet 350(9092):1655–1661PubMed
127.
128.
Zurück zum Zitat Rottoli P, Bianchi Bandinelli ML, Rottoli L, Zazzi M, Panzardi G, Valensin PE (1990) Sarcoidosis and infections by human lymphotropic viruses. Sarcoidosis 7(1):31–33PubMed Rottoli P, Bianchi Bandinelli ML, Rottoli L, Zazzi M, Panzardi G, Valensin PE (1990) Sarcoidosis and infections by human lymphotropic viruses. Sarcoidosis 7(1):31–33PubMed
129.
Zurück zum Zitat Sadikot RT, Dore P, Arnold AG (2001) Sarcoidosis and opportunistic infections. South Med J 94(1):75–77PubMed Sadikot RT, Dore P, Arnold AG (2001) Sarcoidosis and opportunistic infections. South Med J 94(1):75–77PubMed
130.
Zurück zum Zitat Fite E, Fernandez-Figueras MT, Prats R, Vaquero M, Morera J (2006) High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 73(1):20–26PubMed Fite E, Fernandez-Figueras MT, Prats R, Vaquero M, Morera J (2006) High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 73(1):20–26PubMed
131.
Zurück zum Zitat Labro MT (2012) Immunomodulation and infection: back to the future. Expert Rev Anti-Infect Ther 10(3):245–247PubMed Labro MT (2012) Immunomodulation and infection: back to the future. Expert Rev Anti-Infect Ther 10(3):245–247PubMed
132.
Zurück zum Zitat James DG (1991) Mimics of sarcoidosis. Oro-facial granulomatosis (Melkersson-Rosenthal syndrome). Sarcoidosis 8(2):84PubMed James DG (1991) Mimics of sarcoidosis. Oro-facial granulomatosis (Melkersson-Rosenthal syndrome). Sarcoidosis 8(2):84PubMed
133.
Zurück zum Zitat Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137(1):69–73PubMed Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137(1):69–73PubMed
134.
Zurück zum Zitat Miyazaki E, Ando M, Fukami T, Nureki S, Eishi Y, Kumamoto T (2008) Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect? Clin Rheumatol 27(9):1195–1197PubMed Miyazaki E, Ando M, Fukami T, Nureki S, Eishi Y, Kumamoto T (2008) Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect? Clin Rheumatol 27(9):1195–1197PubMed
135.
Zurück zum Zitat Drake WP, Oswald-Richter K, Richmond BW, Isom J, Burke VE, Algood H et al (2013) Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. JAMA Dermatol 149(9):1040–1049PubMedCentralPubMed Drake WP, Oswald-Richter K, Richmond BW, Isom J, Burke VE, Algood H et al (2013) Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. JAMA Dermatol 149(9):1040–1049PubMedCentralPubMed
136.
Zurück zum Zitat Drake W, Richmond BW, Oswald-Richter K, Yu C, Isom JM, Worrell JA et al (2013) Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 30(3):201–211PubMedCentralPubMed Drake W, Richmond BW, Oswald-Richter K, Yu C, Isom JM, Worrell JA et al (2013) Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 30(3):201–211PubMedCentralPubMed
137.
Zurück zum Zitat Chen ES, Moller DR (2011) Sarcoidosis—scientific progress and clinical challenges. Nat Rev Rheumatol 7(8):457–467PubMed Chen ES, Moller DR (2011) Sarcoidosis—scientific progress and clinical challenges. Nat Rev Rheumatol 7(8):457–467PubMed
138.
Zurück zum Zitat Cosma CL, Humbert O, Ramakrishnan L (2004) Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 5(8):828–835PubMed Cosma CL, Humbert O, Ramakrishnan L (2004) Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 5(8):828–835PubMed
139.
Zurück zum Zitat Ehrenfeld M, Levartowsky D (1989) Serum amyloid-A protein and sarcoidosis. Isr J Med Sci 25(8):418–420PubMed Ehrenfeld M, Levartowsky D (1989) Serum amyloid-A protein and sarcoidosis. Isr J Med Sci 25(8):418–420PubMed
140.
Zurück zum Zitat Rubinstein I, Knecht A, de Beer FC, Baum GL, Pras M (1989) Serum amyloid-A protein concentrations in sarcoidosis. Isr J Med Sci 25(8):461–462PubMed Rubinstein I, Knecht A, de Beer FC, Baum GL, Pras M (1989) Serum amyloid-A protein concentrations in sarcoidosis. Isr J Med Sci 25(8):461–462PubMed
141.
Zurück zum Zitat Salazar A, Mana J, Fiol C, Hurtado I, Argimon JM, Pujol R et al (2000) Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis. Atherosclerosis 152(2):497–502PubMed Salazar A, Mana J, Fiol C, Hurtado I, Argimon JM, Pujol R et al (2000) Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis. Atherosclerosis 152(2):497–502PubMed
142.
Zurück zum Zitat De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP, Drent M (2004) The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21(2):127–136PubMed De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP, Drent M (2004) The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21(2):127–136PubMed
143.
Zurück zum Zitat Bargagli E, Magi B, Olivieri C, Bianchi N, Landi C, Rottoli P (2011) Analysis of serum amyloid A in sarcoidosis patients. Respir Med 105(5):775–780PubMed Bargagli E, Magi B, Olivieri C, Bianchi N, Landi C, Rottoli P (2011) Analysis of serum amyloid A in sarcoidosis patients. Respir Med 105(5):775–780PubMed
144.
Zurück zum Zitat Uhlar CM, Whitehead AS (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265(2):501–523PubMed Uhlar CM, Whitehead AS (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265(2):501–523PubMed
145.
Zurück zum Zitat Upragarin N, Landman WJ, Gaastra W, Gruys E (2005) Extrahepatic production of acute phase serum amyloid A. Histol Histopathol 20(4):1295–1307PubMed Upragarin N, Landman WJ, Gaastra W, Gruys E (2005) Extrahepatic production of acute phase serum amyloid A. Histol Histopathol 20(4):1295–1307PubMed
146.
Zurück zum Zitat Eklund KK, Niemi K, Kovanen PT (2012) Immune functions of serum amyloid A. Crit Rev Immunol 32(4):335–348PubMed Eklund KK, Niemi K, Kovanen PT (2012) Immune functions of serum amyloid A. Crit Rev Immunol 32(4):335–348PubMed
147.
Zurück zum Zitat Song C, Hsu K, Yamen E, Yan W, Fock J, Witting PK et al (2009) Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 207(2):374–383PubMed Song C, Hsu K, Yamen E, Yan W, Fock J, Witting PK et al (2009) Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 207(2):374–383PubMed
148.
Zurück zum Zitat Migita K, Koga T, Torigoshi T, Motokawa S, Maeda Y, Jiuchi Y et al (2010) Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes. Clin Exp Immunol 162(2):244–250PubMedCentralPubMed Migita K, Koga T, Torigoshi T, Motokawa S, Maeda Y, Jiuchi Y et al (2010) Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes. Clin Exp Immunol 162(2):244–250PubMedCentralPubMed
149.
Zurück zum Zitat Lane AP, Truong-Tran QA, Myers A, Bickel C, Schleimer RP (2006) Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol 20(1):117–123PubMedCentralPubMed Lane AP, Truong-Tran QA, Myers A, Bickel C, Schleimer RP (2006) Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol 20(1):117–123PubMedCentralPubMed
150.
Zurück zum Zitat Sjoholm K, Palming J, Olofsson LE, Gummesson A, Svensson PA, Lystig TC et al (2005) A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 90(4):2233–2239PubMed Sjoholm K, Palming J, Olofsson LE, Gummesson A, Svensson PA, Lystig TC et al (2005) A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 90(4):2233–2239PubMed
151.
Zurück zum Zitat Shah C, Hari-Dass R, Raynes JG (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108(5):1751–1757PubMed Shah C, Hari-Dass R, Raynes JG (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108(5):1751–1757PubMed
152.
Zurück zum Zitat Ham D, Caouras V, Radzioch D, Gervais F (1997) Degradation of amyloid A precursor protein SAA by macrophage cell lines obtained from amyloid resistant and susceptible strains of mice. Scand J Immunol 45(4):354–360PubMed Ham D, Caouras V, Radzioch D, Gervais F (1997) Degradation of amyloid A precursor protein SAA by macrophage cell lines obtained from amyloid resistant and susceptible strains of mice. Scand J Immunol 45(4):354–360PubMed
153.
Zurück zum Zitat Ostadkarampour M, Eklund A, Moller D, Glader P, Hoglund CO, Linden A et al (2014) Higher levels of IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Lofgren’s syndrome. Clin Exp Immunol Ostadkarampour M, Eklund A, Moller D, Glader P, Hoglund CO, Linden A et al (2014) Higher levels of IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Lofgren’s syndrome. Clin Exp Immunol
Metadaten
Titel
Etiologies of Sarcoidosis
verfasst von
Edward S. Chen
David R. Moller
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 1/2015
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-015-8481-z

Weitere Artikel der Ausgabe 1/2015

Clinical Reviews in Allergy & Immunology 1/2015 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.